OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications
Francesco Semeraro, Francesco Morescalchi, Anna Cancarini, et al.
Diabetes & Metabolism (2019) Vol. 45, Iss. 6, pp. 517-527
Closed Access | Times Cited: 160

Showing 1-25 of 160 citing articles:

The Role of Oxidative Stress and Antioxidants in Diabetic Wound Healing
Liling Deng, Chenzhen Du, Peiyang Song, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 419

Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies
María L. Rodríguez, Salvador Pérez, Salvador Mena, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-18
Open Access | Times Cited: 192

Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
Winfried M. K. Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Eye (2020) Vol. 34, Iss. S1, pp. 1-51
Open Access | Times Cited: 158

Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Jingfa Zhang, Jingxiang Zhang, Chaoyang Zhang, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3362-3362
Open Access | Times Cited: 138

Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy
Guo-Tong Xu, Jingfa Zhang, Lei Tang
Neural Regeneration Research (2022) Vol. 18, Iss. 5, pp. 976-976
Open Access | Times Cited: 117

Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy
Xue Chen, Ying Wang, Jianan Wang, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 2, pp. 294-318
Open Access | Times Cited: 30

Endothelial Dysfunction in Diabetic Retinopathy
Fu Gui, Zhipeng You, Shuhua Fu, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 128

Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications
Qing Xiong, Jie Liu, Yancheng Xu
International Journal of Endocrinology (2019) Vol. 2019, pp. 1-8
Open Access | Times Cited: 114

Diabetic Retinopathy–An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes
Stephen H. Sinclair, Stanley S. Schwartz
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 102

The Coming Age of Flavonoids in the Treatment of Diabetic Complications
Teresa Caro-Ordieres, Gema Marín‐Royo, Lucas Opazo-Ríos, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 346-346
Open Access | Times Cited: 87

Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury
Steven F. Abcouwer, Sumathi Shanmugam, Arivalagan Muthusamy, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 64

RIP3-mediated microglial necroptosis promotes neuroinflammation and neurodegeneration in the early stages of diabetic retinopathy
Zijing Huang, Jiajian Liang, Shao-Lang Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 23

Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform
Sara Rezzola, Alessandra Loda, Michela Corsini, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 57

New Highlights of Resveratrol: A Review of Properties against Ocular Diseases
Dominique Delmas, Clarisse Cornebise, Flavie Courtaut, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1295-1295
Open Access | Times Cited: 55

Adjuvant Therapies in Diabetic Retinopathy as an Early Approach to Delay Its Progression: The Importance of Oxidative Stress and Inflammation
Ricardo Raúl Robles-Rivera, José Alberto Castellanos‐González, Cecilia Olvera-Montaño, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-23
Open Access | Times Cited: 53

From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
Azza Dammak, Fernando Huete‐Toral, Carlos Carpena‐Torres, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1376-1376
Open Access | Times Cited: 53

miR-125a-5p attenuates macrophage-mediated vascular dysfunction by targeting Ninjurin1
Su Jung Hwang, Bum Ju Ahn, Minwook Shin, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1199-1210
Open Access | Times Cited: 36

The pathophysiological mechanisms underlying diabetic retinopathy
Lindan Wei, Xin Sun, Chenxi Fan, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 35

The Platelet-to-Lymphocyte Ratio Predicts Diabetic Retinopathy in Type 2 Diabetes Mellitus
Jing Zeng, Min Chen, Feng Qiu, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 3617-3626
Open Access | Times Cited: 29

Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management
Arpon Biswas, Abhijit Deb Choudhury, Sristi Agrawal, et al.
Journal of Ocular Pharmacology and Therapeutics (2023) Vol. 40, Iss. 1, pp. 13-33
Closed Access | Times Cited: 19

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
Irini Chatziralli, Anat Loewenstein
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1137-1137
Open Access | Times Cited: 35

Diabetic Retinopathy
BassirouA M. Mounirou, Nouhou Diori Adam, AbbaK H. Yakoura, et al.
Indian Journal of Endocrinology and Metabolism (2022) Vol. 26, Iss. 2, pp. 111-118
Open Access | Times Cited: 24

Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy
Gabriella Lupo, Aleksandra Agafonova, Alessia Cosentino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 913-913
Open Access | Times Cited: 15

m6A Modification—Association with Oxidative Stress and Implications on Eye Diseases
Yueqi Ni, Hong Zhang, Liang Chu, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 510-510
Open Access | Times Cited: 15

Extracellular Vesicles and MicroRNA: Putative Role in Diagnosis and Treatment of Diabetic Retinopathy
Beatriz Martins, Madania Amorim, Flávio Reis, et al.
Antioxidants (2020) Vol. 9, Iss. 8, pp. 705-705
Open Access | Times Cited: 35

Page 1 - Next Page

Scroll to top